Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2023-05-15

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$593.6m reported value -8.4% vs Q3 2022
28positions
70.6%in top 10
7 new 4 added 6 reduced 10 sold out vs Q3 2022

Holdings, Q4 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 2,699,865 $78.9m13.29% 13.29% AddedShares held: Q3 2022 2.1m, Q4 2022 2.7m +569.6k +569,557 26.7%
2 ACLARIS THERAPEUTICS INC COM ACRS ACRS 4,563,962 $71.9m12.11% 12.11% UnchangedShares held: Q3 2022 4.6m, Q4 2022 4.6m
3 AXSOME THERAPEUTICS INC COM AXSM AXSM 670,718 $51.7m8.71% 8.71% NewShares held: Q3 2022 0, Q4 2022 670.7k
4 COGENT BIOSCIENCES INC COM COGT COGT 4,038,117 $46.7m7.86% 7.86% UnchangedShares held: Q3 2022 4.0m, Q4 2022 4.0m
5 TERNS PHARMACEUTICALS INC COM COM 3,707,891 $37.7m6.36% 6.36% UnchangedShares held: Q3 2022 3.7m, Q4 2022 3.7m
6 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 3,517,125 $34.2m5.76% 5.76% AddedShares held: Q3 2022 3.3m, Q4 2022 3.5m +184.0k +183,971 5.5%
7 CELCUITY INC COM CELC CELC 2,105,386 $29.5m4.97% 4.97% NewShares held: Q3 2022 0, Q4 2022 2.1m
8 DICE THERAPEUTICS INC COM COM 819,000 $25.6m4.30% 4.30% AddedShares held: Q3 2022 765.0k, Q4 2022 819.0k +54.0k +54,021 7.1%
9 AEROVATE THERAPEUTICS INC COM COM 747,869 $21.9m3.69% 3.69% ReducedShares held: Q3 2022 833.9k, Q4 2022 747.9k -86.1k -86,058 -10.3%
10 PLIANT THERAPEUTICS INC COM PLRX PLRX 1,080,000 $20.9m3.52% 3.52% UnchangedShares held: Q3 2022 1.1m, Q4 2022 1.1m
11 KALVISTA PHARMACEUTICALS INC COM KALV KALV 2,916,667 $19.7m3.32% 3.32% NewShares held: Q3 2022 0, Q4 2022 2.9m
12 NOVAVAX INC COM NEW NVAX NVAX 1,879,894 $19.3m3.26% 3.26% NewShares held: Q3 2022 0, Q4 2022 1.9m
13 MERUS N V COM MRUS MRUS 1,226,214 $19.0m3.20% 3.20% NewShares held: Q3 2022 0, Q4 2022 1.2m
14 CABALETTA BIO INC COM CABA CABA 1,895,285 $17.5m2.95% 2.95% NewShares held: Q3 2022 0, Q4 2022 1.9m
15 ANNEXON INC COM ANNX ANNX 3,220,050 $16.6m2.80% 2.80% UnchangedShares held: Q3 2022 3.2m, Q4 2022 3.2m
16 VECTIVBIO HLDG AG ORD SHS ORD SHS 1,866,000 $16.2m2.72% 2.72% NewShares held: Q3 2022 0, Q4 2022 1.9m
17 PROVENTION BIO INC COM PRVB PRVB 1,118,653 $11.8m1.99% 1.99% UnchangedShares held: Q3 2022 1.1m, Q4 2022 1.1m
18 SAVARA INC COM SVRA SVRA 6,351,531 $9.8m1.66% 1.66% AddedShares held: Q3 2022 4.6m, Q4 2022 6.4m +1.8m +1,796,493 39.4%
19 MILESTONE PHARMACEUTICALS IN COM MIST MIST 2,208,812 $8.7m1.47% 1.47% ReducedShares held: Q3 2022 2.4m, Q4 2022 2.2m -216.9k -216,925 -8.9%
20 LIANBIO SPONSORED ADS LIANY LIANY 4,793,047 $7.9m1.32% 1.32% ReducedShares held: Q3 2022 5.4m, Q4 2022 4.8m -585.3k -585,294 -10.9%
21 MARINUS PHARMACEUTICALS INC COM NEW MRNS MRNS 1,770,705 $7.0m1.19% 1.19% ReducedShares held: Q3 2022 3.2m, Q4 2022 1.8m -1.4m -1,386,098 -43.9%
22 TREVI THERAPEUTICS INC COM TRVI TRVI 3,050,022 $5.9m0.99% 0.99% UnchangedShares held: Q3 2022 3.1m, Q4 2022 3.1m
23 FULCRUM THERAPEUTICS INC COM FULC FULC 447,326 $3.3m0.55% 0.55% ReducedShares held: Q3 2022 1.2m, Q4 2022 447.3k -752.7k -752,674 -62.7%
24 LYRA THERAPEUTICS INC COM LYRA LYRA 924,170 $2.9m0.49% 0.49% UnchangedShares held: Q3 2022 924.2k, Q4 2022 924.2k
25 INOZYME PHARMA INC COM COM 2,709,987 $2.8m0.48% 0.48% UnchangedShares held: Q3 2022 2.7m, Q4 2022 2.7m
26 ATYR PHARMA INC COM NEW ATYR ATYR 1,171,436 $2.6m0.43% 0.43% ReducedShares held: Q3 2022 1.4m, Q4 2022 1.2m -227.5k -227,453 -16.3%
27 AFFIMED N V COM COM 1,428,571 $1.8m0.30% 0.30% UnchangedShares held: Q3 2022 1.4m, Q4 2022 1.4m
28 RALLYBIO CORP COM COM 268,532 $1.8m0.30% 0.30% UnchangedShares held: Q3 2022 268.5k, Q4 2022 268.5k

Sold out since Q3 2022

SecurityTickerShares held beforeValue then
TRICIDA INC TCDA TCDA 9,050,064 $94.8m9.1m shares
RELMADA THERAPEUTICS INC RLMD RLMD 1,518,056 $56.2m1.5m shares
GOSSAMER BIO INC GOSS GOSS 1,747,000 $20.9m1.7m shares
INSTIL BIO INC 4,105,779 $19.9m4.1m shares
AKOUOS INC 2,800,566 $18.9m2.8m shares
VENTYX BIOSCIENCES INC VTYX VTYX 207,925 $7.3m207.9k shares
PROMETHEUS BIOSCIENCES INC 121,663 $7.2m121.7k shares
ALTIMMUNE INC ALT ALT 369,306 $4.7m369.3k shares
IMMUNOCORE HLDGS PLC IMCR IMCR 94,605 $4.4m94.6k shares
CELLDEX THERAPEUTICS INC NEW CLDX CLDX 75,000 $2.1m75.0k shares